Impact Biomedical Investor News: Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO

Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO

Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

IBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Impact BioMedical Inc. Is Fair to Shareholders

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

Impact Biomedical Inc. Announcement Stock Activity/Pricing

Impact BioMedical Inc. to Present at The Microcap Conference

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

Impact BioMedical Inc. Announces Pricing of Initial Public Offering